Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Nordic Climate Groups svenska dotterbolag Kylgruppen förvärvar Bromma Energi, ett specialistbolag inom installation och service av värmepumpssystem.
-
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code” 1. KEY INFORMATION...
-
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...
-
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
Le Groupe Dekuple poursuit sa croissance européenne avec une prise de participation majoritaire dans subko&co en Pologne Paris, le 1er juillet 2026 (8h00) - Le Groupe DEKUPLE, Leader Européen de...
-
DEKUPLE Group continues its European growth with a majority stake acquisition in subko&co in Poland Paris, July 1st, 2026 (8:00 a.m.) – DEKUPLE Group, a European leader in communication and data...
-
EUROBIO SCIENTIFIC FINALISE L'ACQUISITION DE LA DIVISION « LAB PRODUCTS1 » DE CAREDX DÉDIÉE À LA TRANSPLANTATION Accélération du plan stratégique d’Eurobio visant à devenir un leader du diagnostic...
-
EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISION Acceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leaderCreation...